Journal
FRONTIERS IN CHEMISTRY
Volume 8, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fchem.2020.00593
Keywords
galectins; glycomimetics; glycans; molecular recogntion; drug design
Categories
Funding
- European Research Council (RECGLYCANMR) [788143]
- ISCIII [PRB3 IPT17/0019]
- Agencia Estatal de Investigacion (Spain) [RTI2018-094751-B-C21]
- Ramon y Cajal
- Severo Ochoa Excellence Accreditation [SEV-2016-0644]
- European Research Council (ERC) [788143] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
Among glycan-binding proteins, galectins, beta-galactoside-binding lectins, exhibit relevant biological roles and are implicated in many diseases, such as cancer and inflammation. Their involvement in crucial pathologies makes them interesting targets for drug discovery. In this review, we gather the last approaches toward the specific design of glycomimetics as potential drugs against galectins. Different approaches, either using specific glycomimetic molecules decorated with key functional groups or employing multivalent presentations of lactose and N-acetyl lactosamine analogs, have provided promising results for binding and modulating different galectins. The review highlights the results obtained with these approximations, from the employment of S-glycosyl compounds to peptidomimetics and multivalent glycopolymers, mostly employed to recognize and/or detecthGal-1 andhGal-3.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available